{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:17:44Z","timestamp":1791339464663,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stichting kinderen en kansen","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]},{"DOI":"10.13039\/501100011010","name":"Stichting Zabawas","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100011010","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009622","name":"Zeldzame Ziekten Fonds","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100009622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The phenotypic spectrum of many rare disorders is much wider than previously considered. Mucopolysaccharidosis type III (Sanfilippo syndrome, MPS III), is a lysosomal storage disorder traditionally considered to be characterized by childhood onset, progressive neurocognitive deterioration with a rapidly or slowly progressing phenotype. The presented MPS III case series demonstrates adult onset phenotypes with mild cognitive impairment or non-neuronopathic phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this case series all adult MPS III patients with a mild- or non-neuronopathic phenotype, who attend the outpatient clinic of 3 expert centers for lysosomal storage disorders were included. A mild- or non-neuronopathic phenotype was defined as having completed regular secondary education and attaining a level of independency during adulthood, involving either independent living or a paid job.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve patients from six families, with a median age at diagnosis of 43\u2009years (range 3\u201368) were included (11 MPS IIIA, 1 MPS IIIB). In the four index patients symptoms which led to diagnostic studies (whole exome sequencing and metabolomics) resulting in the diagnosis of MPS III; two patients presented with retinal dystrophy, one with hypertrophic cardiomyopathy and one with neurocognitive decline. The other eight patients were diagnosed by family screening. At a median age of 47\u2009years (range 19\u201374) 9 out of the 12 patients had normal cognitive functions. Nine patients had retinal dystrophy and 8 patients hypertrophic cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We show the very mild end of the phenotypic spectrum of MPS III, ranging from late-onset stable neurocognitive impairment to a fully non-neuronopathic phenotype. Awareness of this phenotype could lead to timely diagnosis and genetic counseling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-019-1232-0","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:03:06Z","timestamp":1573556586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype"],"prefix":"10.1186","volume":"14","author":[{"given":"Stephanie C. M.","family":"Nijmeijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Ingeborg","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke J. A.","family":"Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina M.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Langendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Pieter","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Roosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet A. E. M.","family":"Wagenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"publisher","first-page":"278-287.e4","DOI":"10.1016\/j.jpeds.2015.11.079","volume":"170","author":"Elsa G. Shapiro","year":"2016","unstructured":"Shapiro EG, Nestrasil I, Delaney KA, et al. A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA. J Pediatr. 2016. https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.079.","journal-title":"The Journal of Pediatrics"},{"issue":"Suppl 5","key":"1232_CR2","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50(Suppl 5):v4\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/ker394.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1232_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","volume":"125","author":"Brian W. Bigger","year":"2018","unstructured":"Bigger BW, Begley DJ, Virgintino D, Pshezhetsky AV. Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders. Mol Genet Metabol. 2018. https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.003.","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"1232_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","volume":"37","author":"LD Archer","year":"2014","unstructured":"Archer LD, Langford-Smith KJ, Bigger BW, Fildes JE. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity. J Inherit Metabol Dis. 2014;37(1):1\u201312. https:\/\/doi.org\/10.1007\/s10545-013-9613-3.","journal-title":"J Inherit Metabol Dis"},{"issue":"2","key":"1232_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","volume":"31","author":"MJ Valstar","year":"2008","unstructured":"Valstar MJ, Ruijter GJ, van Diggelen OP, et al. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis. 2008;31(2):240\u201352. https:\/\/doi.org\/10.1007\/s10545-008-0838-5.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1232_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13023-017-0717-y","volume":"12","author":"C Lavery","year":"2017","unstructured":"Lavery C, Hendriksz CJ, Jones SA. Mortality in patients with Sanfilippo syndrome. Orphanet J Rare Dis. 2017;12(1):168. https:\/\/doi.org\/10.1186\/s13023-017-0717-y.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1232_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2013.03.004","volume":"109","author":"J de Ruijter","year":"2013","unstructured":"de Ruijter J, Maas M, Janssen A, Wijburg FA. High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study. Mol Genet Metab. 2013;109(1):49\u201353. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.004.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1232_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jimd.12015","volume":"42","author":"Stephanie C. M. Nijmeijer","year":"2019","unstructured":"Nijmeijer SCM, de Bruin-Bon R, Wijburg FA, Kuipers IM. Cardiac disease in mucopolysaccharidosis type III. J Inherit Metab Dis. 2018. https:\/\/doi.org\/10.1002\/jimd.12015.","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"1232_CR9","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1542\/peds.2007-0282","volume":"120","author":"A Meyer","year":"2007","unstructured":"Meyer A, Kossow K, Gal A, et al. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics. 2007;120(5):e1255\u201361. https:\/\/doi.org\/10.1542\/peds.2007-0282.","journal-title":"Pediatrics"},{"issue":"6","key":"1232_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","volume":"33","author":"MJ Valstar","year":"2010","unstructured":"Valstar MJ, Bruggenwirth HT, Olmer R, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis. 2010;33(6):759\u201367. https:\/\/doi.org\/10.1007\/s10545-010-9199-y.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1232_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ajmg.c.30142","volume":"145c","author":"U Moog","year":"2007","unstructured":"Moog U, van Mierlo I, van Schrojenstein Lantman-de Valk HM, et al. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am J Med Genet C Semin Med Genet. 2007;145c(3):293\u2013301. https:\/\/doi.org\/10.1002\/ajmg.c.30142.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"1232_CR12","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/ajmg.a.34053","volume":"155a","author":"N Muschol","year":"2011","unstructured":"Muschol N, Pohl S, Meyer A, et al. Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. Am J Med Genet C Semin Med Genet. 2011;155a(7):1634\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.34053.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"1232_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/humu.20738","volume":"29","author":"Ann Meyer","year":"2008","unstructured":"Meyer A, Kossow K, Gal A, et al. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Human mutation, 29 (5), 770. 2008. https:\/\/doi.org\/10.1002\/humu.20738.","journal-title":"Human Mutation"},{"issue":"1","key":"1232_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ajmg.a.30552","volume":"133a","author":"O Gabrielli","year":"2005","unstructured":"Gabrielli O, Coppa GV, Bruni S, et al. An adult Sanfilippo type A patient with homozygous mutation R206P in the sulfamidase gene. Am J Med Genet C Semin Med Genet. 2005;133a(1):85\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.30552.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"1232_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ejhg.2011.126","volume":"20","author":"KK Selmer","year":"2012","unstructured":"Selmer KK, Gilfillan GD, Stromme P, et al. A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions. Euro J Human Genet. 2012;20(1):58\u201363. https:\/\/doi.org\/10.1038\/ejhg.2011.126.","journal-title":"Euro J Human Genet"},{"issue":"4","key":"1232_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ajmg.a.20068","volume":"118a","author":"JL Van Hove","year":"2003","unstructured":"Van Hove JL, Wevers RA, Van Cleemput J, et al. Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome. Am J Med Genet C Semin Med Genet. 2003;118a(4):382\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.20068.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"1232_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00415-004-0368-5","volume":"251","author":"EG Berger-Plantinga","year":"2004","unstructured":"Berger-Plantinga EG, Vanneste JA, Groener JE, van Schooneveld MJ. Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters. J Neurol. 2004;251(4):479\u201381. https:\/\/doi.org\/10.1007\/s00415-004-0368-5.","journal-title":"J Neurol"},{"key":"1232_CR18","unstructured":"Centraal Bureau voor de Statistiek. Educational Level. Available from: http:\/\/statline.cbs.nl\/Statweb\/publication\/?VW=T&DM=SLNL&PA=82275NED&D1=0&D2=0&D3=1&D4=0&D5=0-1,7,11&D6\u2009=\u20099,14,19,24,29,34,39,44,49,54,59,64,l&HD\u2009=\u2009170,515\u20130932&HDR\u2009=\u2009T,G1,G3,G5&STB\u2009=\u2009G2,G4. Accessed on 05-Apr-2019."},{"issue":"6","key":"1232_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/(sici)1098-1004 (1997)10:6<479::Aid-humu10>3.0.Co;2-x","volume":"10","author":"S Bunge","year":"1997","unstructured":"Bunge S, Ince H, Steglich C, et al. Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A). Hum Mutat. 1997;10(6):479\u201385. https:\/\/doi.org\/10.1002\/(sici1098-1004(1997)10:6<479::Aid-humu10>3.0.Co;2-x.","journal-title":"Hum Mutat"},{"issue":"9","key":"1232_CR20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/hmg\/6.9.1573","volume":"6","author":"B Weber","year":"1997","unstructured":"Weber B, Guo XH, Wraith JE, et al. Novel mutations in Sanfilippo A syndrome: implications for enzyme function. Hum Mol Genet. 1997;6(9):1573\u20139.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1232_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.37.9.704","volume":"37","author":"CE Beesley","year":"2000","unstructured":"Beesley CE, Young EP, Vellodi A, Winchester BG. Mutational analysis of Sanfilippo syndrome type A (MPS IIIA): identification of 13 novel mutations. J Med Genet. 2000;37(9):704\u20137.","journal-title":"J Med Genet"},{"key":"1232_CR22","unstructured":"VarCards: an integrated genetic and clinical database for coding variants in the human genome Available from: http:\/\/varcards.biols.ac.cn\/. Accessed on 26-Feb-2019."},{"issue":"1","key":"1232_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/301682","volume":"62","author":"HG Zhao","year":"1998","unstructured":"Zhao HG, Aronovich EL, Whitley CB. Genotype-phenotype correspondence in Sanfilippo syndrome type B. Am J Hum Genet. 1998;62(1):53\u201363. https:\/\/doi.org\/10.1086\/301682.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1232_CR24","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1073\/pnas.93.12.6101","volume":"93","author":"HG Zhao","year":"1996","unstructured":"Zhao HG, Li HH, Bach G, et al. The molecular basis of Sanfilippo syndrome type B. Proc Natl Acad Sci U S A. 1996;93(12):6101\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1232_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","volume":"51","author":"JL Ashworth","year":"2006","unstructured":"Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006;51(1):1\u201317. https:\/\/doi.org\/10.1016\/j.survophthal.2005.11.007.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"1232_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","volume":"93","author":"GJ Ruijter","year":"2008","unstructured":"Ruijter GJ, Valstar MJ, van de Kamp JM, et al. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Gen Metab. 2008;93(2):104\u201311. https:\/\/doi.org\/10.1016\/j.ymgme.2007.09.011.","journal-title":"Mol Gen Metab"},{"issue":"2","key":"1232_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/s1047951109003576","volume":"19","author":"V Fesslova","year":"2009","unstructured":"Fesslova V, Corti P, Sersale G, et al. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009;19(2):170\u20138. https:\/\/doi.org\/10.1017\/s1047951109003576.","journal-title":"Cardiol Young"},{"issue":"2","key":"1232_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ymgme.2018.04.010","volume":"124","author":"Carolyn M. Wilhelm","year":"2018","unstructured":"Wilhelm CM, Truxal KV, McBride KL, et al. Natural history of echocardiographic abnormalities in mucopolysaccharidosis III. Mol Genet Metab. 2018. https:\/\/doi.org\/10.1016\/j.ymgme.2018.04.010.","journal-title":"Molecular Genetics and Metabolism"},{"issue":"10","key":"1232_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/genes8100256","volume":"8","author":"Jason Comander","year":"2017","unstructured":"Comander J, Weigel-DiFranco C, Maher M, et al. The Genetic Basis of Pericentral Retinitis Pigmentosa-A Form of Mild Retinitis Pigmentosa. Genes. 2017;8(10). https:\/\/doi.org\/10.3390\/genes8100256.","journal-title":"Genes"},{"issue":"13","key":"1232_CR30","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1093\/hmg\/ddv118","volume":"24","author":"L Haer-Wigman","year":"2015","unstructured":"Haer-Wigman L, Newman H, Leibu R, et al. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT). Hum Mol Genet. 2015;24(13):3742\u201351. https:\/\/doi.org\/10.1093\/hmg\/ddv118.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1232_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jimd.12015","volume":"42","author":"Stephanie C. M. Nijmeijer","year":"2019","unstructured":"Nijmeijer S., de Bruin-Bon, H., Wijburg, F.,Kuipers, I., Cardiac disease in mucopolysaccharidosis type III. 2018: J Inherit Metab Dis. https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/jimd.12015.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-6-43","volume":"6","author":"MJ Valstar","year":"2011","unstructured":"Valstar MJ, Marchal JP, Grootenhuis M, et al. Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome). Orph J Rare Dis. 2011;6:43. https:\/\/doi.org\/10.1186\/1750-1172-6-43.","journal-title":"Orph J Rare Dis"},{"issue":"6","key":"1232_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","volume":"24","author":"L Henneman","year":"2016","unstructured":"Henneman L, Borry P, Chokoshvili D, et al. Responsible implementation of expanded carrier screening. European journal of human genetics. 2016;24(6):e1\u2013e12. https:\/\/doi.org\/10.1038\/ejhg.2015.271.","journal-title":"European journal of human genetics"},{"issue":"2","key":"1232_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymgme.2018.10.006","volume":"126","author":"FA Wijburg","year":"2019","unstructured":"Wijburg FA, Whitley CB, Muenzer J, et al. Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial. Mol Gen Metab. 2019;126(2):121\u201330. https:\/\/doi.org\/10.1016\/j.ymgme.2018.10.006.","journal-title":"Mol Gen Metab"},{"key":"1232_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","volume":"269","author":"CI van Capelle","year":"2018","unstructured":"van Capelle CI, Poelman E, Frohn-Mulder IM, et al. Cardiac outcome in classic infantile Pompe disease after 13\u2009years of treatment with recombinant human acid alpha-glucosidase. Int J Cardiol. 2018;269:104\u201310. https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.091.","journal-title":"Int J Cardiol"},{"key":"1232_CR36","unstructured":"ClinicalTrials.gov Identifier NCT03300453. Available from: https:\/\/clinicaltrials.gov. Accessed on 09-Jan-2019."},{"key":"1232_CR37","unstructured":"ClinicalTrials.gov Identifier NCT02716246 Available from: https:\/\/clinicaltrials.gov. Accessed on 09-Jan-2019."},{"key":"1232_CR38","unstructured":"ClinicalTrials.gov Identifier NCT03315182 Available from: https:\/\/clinicaltrials.gov. Accessed on 09-Jan-2019."},{"key":"1232_CR39","unstructured":"ClinicalTrials.gov Identifier NCT03612869 Available from: https:\/\/clinicaltrials.gov. Accessed on 09-Jan-2019."},{"key":"1232_CR40","unstructured":"EudraCT Number: 2015\u2013000359-26 Available from: https:\/\/www.clinicaltrialsregister.eu. Accessed on: 09-Jan-2019."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1232-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T19:30:36Z","timestamp":1605036636000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1232-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1232-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were in accordance with the Principles of the Declaration of Helsinki. The study was approved by the local ethics committee of the coordinating center, the Medical Ethical Committee of the Amsterdam University Medical Centers, location AMC. Written informed consent was obtained from patients for the publication of photographs in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was obtained from all patients for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}